Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.19.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2017 $ 21,391 $ 60 $ 165,825 $ (340) $ (144,154)
Balance (in shares) at Dec. 31, 2017   59,943      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (7,899)       (7,899)
Equipois supply and sales earn-outs 28   28    
Equipois supply and sales earn-outs (in shares)   18      
Equity incentive plan (62)   (62)    
Equity incentive plan (in shares)   52      
Matching contribution to 401(k) plan 508   508    
Matching contribution to 401(k) plan (in shares)   221      
In lieu of employee cash bonus 190   190    
In lieu of employee cash bonus (in shares)   121      
Stock-based compensation expense 892   892    
Foreign currency translation adjustments (207)     (207)  
Ending Balance at Mar. 31, 2018 14,841 $ 60 167,381 (547) (152,053)
Balance (in shares) at Mar. 31, 2018   60,355      
Beginning Balance at Dec. 31, 2017 21,391 $ 60 165,825 (340) (144,154)
Balance (in shares) at Dec. 31, 2017   59,943      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (15,877)        
Ending Balance at Jun. 30, 2018 7,626 $ 61 167,823 (227) (160,031)
Balance (in shares) at Jun. 30, 2018   60,832      
Beginning Balance at Mar. 31, 2018 14,841 $ 60 167,381 (547) (152,053)
Balance (in shares) at Mar. 31, 2018   60,355      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (7,978)       (7,978)
Equity incentive plan 1 $ 1      
Equity incentive plan (in shares)   454      
In lieu of employee cash bonus 40   40    
In lieu of employee cash bonus (in shares)   23      
Stock-based compensation expense 402   402    
Foreign currency translation adjustments 320     320  
Ending Balance at Jun. 30, 2018 7,626 $ 61 167,823 (227) (160,031)
Balance (in shares) at Jun. 30, 2018   60,832      
Beginning Balance at Dec. 31, 2018 2,728 $ 63 173,903 (92) (171,146)
Balance (in shares) at Dec. 31, 2018   62,963      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,551)       (6,551)
Equity financing, net 7,305 $ 5 7,300    
Equity financing, net (in shares)   4,362      
Equipois supply and sales earn-outs 22   22    
Equipois supply and sales earn-outs (in shares)   18      
Equity incentive plan 55   55    
Equity incentive plan (in shares)   45      
Matching contribution to 401(k) plan 191   191    
Matching contribution to 401(k) plan (in shares)   141      
Stock-based compensation expense 636   636    
Foreign currency translation adjustments 148     148  
Ending Balance at Mar. 31, 2019 4,534 $ 68 182,107 56 (177,697)
Balance (in shares) at Mar. 31, 2019   67,529      
Beginning Balance at Dec. 31, 2018 2,728 $ 63 173,903 (92) (171,146)
Balance (in shares) at Dec. 31, 2018   62,963      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (9,617)        
Ending Balance at Jun. 30, 2019 5,404 $ 75 186,142 (50) (180,763)
Balance (in shares) at Jun. 30, 2019   74,895      
Beginning Balance at Mar. 31, 2019 4,534 $ 68 182,107 56 (177,697)
Balance (in shares) at Mar. 31, 2019   67,529      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,066)       (3,066)
Equity financing, net 2,393 $ 6 2,387    
Equity financing, net (in shares)   6,667      
Equity incentive plan 173   173    
Equity incentive plan (in shares)   141      
In lieu of employee cash bonus 919 $ 1 918    
In lieu of employee cash bonus (in shares)   558      
Stock-based compensation expense 557   557    
Foreign currency translation adjustments (106)     (106)  
Ending Balance at Jun. 30, 2019 $ 5,404 $ 75 $ 186,142 $ (50) $ (180,763)
Balance (in shares) at Jun. 30, 2019   74,895